SQZ Biotechnologies Co

NYSE:SQZ   4:00:00 PM EDT
2.65
+0.02 (+0.76%)
Earnings Announcements

Sqz Biotechnologies Reports Third Quarter 2022 Financial Results

Published: 11/09/2022 21:37 GMT
SQZ Biotechnologies Co (SQZ) - Sqz Biotechnologies Reports Third Quarter 2022 Financial Results and Recent Portfolio Updates.
As of September 30, 2022, the Company Had Cash and Cash Equivalents of $84.2 Million.
Qtrly Net Loss per Share, Basic and Diluted $0.77.
Q3 Earnings per Share View $-0.84 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $4.7 Million
Adjusted EPS is expected to be -$0.78

Next Quarter Revenue Guidance is expected to be $4.11 Million
Next Quarter EPS Guidance is expected to be -$0.81

More details on our Analysts Page.